A Coiled-Coil Oligomerization Domain of Bcr Is Essential for the Transforming Function of Bcr-Abl Oncoproteins

References

• Ben-Neriah, Y., A. Bernards, M. Paskind, G. Q. Daley, and D. Baltimore. 1986. Alternative 5′ exons in c-abl mRNA. Cell 44:577–586.
   PubMed Web of Science ®Google Scholar
• Ben-Neriah, Y., G. Q. Daley, A. M. Mes-Masson, O. N. Witte, and D. Baltimore. 1986. The chronic myelogenous leukemia-specific p210 protein is the product of the bcr/abl hybrid gene. Science 233:212–214.
   PubMed Web of Science ®Google Scholar
• Campbell, M., W. Li, and R. B. Arlinghaus. 1990. P210 BCR-ABL is complexed to pl60 BCR and ph-p53 proteins in K562 cells. Oncogene 5:773–776.
   PubMedGoogle Scholar
• Cicchetti, P., B. J. Mayer, G. Thiel, and D. Baltimore. 1992. Identification of a protein that binds to the SH3 domain of Abl and is similar to Bcr and GAP-rho. Science 257:803–806.
   PubMedGoogle Scholar
• Clark, S. S., J. McLaughlin, M. Timmons, A. M. Pendergast, Y. Ben-Neriah, L. W. Dow, W. Crist, G. Rovera, S. D. Smith, and O. N. Witte. 1988. Expression of a distinctive bcr/abl oncogene in Ph1-positive acute lymphocytic leukemia (ALL). Science 239:775–777.
   PubMed Web of Science ®Google Scholar
• Clos, J., T. Westwood, P. B. Becker, S. Wilson, K. Lambert, and C. Wu. 1990. Molecular cloning and expression of a hexameric Drosophila heat shock factor subject to negative regulation. Cell 63:1085–1097.
   PubMed Web of Science ®Google Scholar
• Cohen, C., and D. A. D. Parry. 1986. α-Helical coiled coils: a widespread motif in proteins. Trends Biochem. Sci. 11:245–248.
   Web of Science ®Google Scholar
• Daley, G. Q., and D. Baltimore. 1988. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific p210bcr/abl protein. Proc. Natl. Acad. Sci. USA 85:9312–9316.
   PubMed Web of Science ®Google Scholar
• Daley, G. Q., R. A. Van Etten, and D. Baltimore. 1990. Induction of chronic myelogenous leukemia in mice by the p210bcr/abl gene of the Philadelphia chromosome. Science 247:824–830.
   PubMed Web of Science ®Google Scholar
• de Klein, A., A. D. van Kessel, G. Grosveld, C. R. Bartram, A. Hagemeyer, D. Bootsma, N. K. Spurr, N. Heisterkamp, J. Groffen, and J. R. Stephenson. 1982. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelogenous leukemia. Nature (London) 300:765–767.
   PubMed Web of Science ®Google Scholar
• Diekmann, D., S. Brill, M. D. Garrett, N. Totty, J. Hsuan, C. Monfries, C. Hall, L. Lim, and A. Hall. 1991. BCR encodes a GTPase activating protein for p21rac. Nature (London) 351:400–402.
   PubMed Web of Science ®Google Scholar
• Field, J., J. Nikawa, D. Broek, B. MacDonald, L. Rodgers, I. A. Wilson, R. A. Lerner, and M. Wigler. 1988. Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method. Mol. Cell. Biol. 8:2159–2165.
   PubMed Web of Science ®Google Scholar
• Franz, W. M., P. Berger, and J. Y. J. Wang. 1989. Deletion of an N-terminal regulatory domain of the c-Abl tyrosine kinase activates its oncogenic potential. EMBO J. 8:137–147.
   PubMed Web of Science ®Google Scholar
• Heisterkamp, N., G. Jenster, J. ten Hoeve, D. Zovich, P. K. Pattengale, and J. Groffen. 1990. Acute leukemia in bcr/abl transgenic mice. Nature (London) 344:251–253.
   PubMed Web of Science ®Google Scholar
• Heisterkamp, N., K. Stain, and J. Groffen. 1985. Structural organization of the bcr gene and its role in the Ph1 translocation. Nature (London) 315:758–761.
   PubMed Web of Science ®Google Scholar
• Heisterkamp, N., J. R. Stephenson, J. Groffen, P. F. Hansen, A. de Klein, C. R. Bartram, and G. Grosveld. 1983. Localization of the cc-abl oncogene adjacent to a translocation break point in chronic myelocytic leukemia. Nature (London) 306:239–242.
   PubMed Web of Science ®Google Scholar
• Hermans, A., N. Heisterkamp, M. von Lindern, S. van Baal, D. Meyer, D. van der Plas, L. M. Wiedemann, J. Groffen, D. Bootsma, and G. Grosveld. 1987. Unique fusion of bcr and c-abl genes in Philadelphia chromosome-positive acute lymphoblastic leukemia. Cell 51:33–40.
   PubMed Web of Science ®Google Scholar
• Honegger, A. M., R. M. Kris, A. Ullrich, and J. Schlessinger. 1989. Evidence that autophosphorylation of solubilized EGF-receptors is mediated by intermolecular cross phosphorylation. Proc. Natl. Acad. Sci. USA 86:925–929.
   PubMed Web of Science ®Google Scholar
• Honegger, A. M., A. Schmidt, A. Ullrich, and J. Schlessinger. 1990. Evidence for epidermal growth factor (EGF)-induced intermolecular autophosphorylation of the EGF receptors in living cells. Mol. Cell. Biol. 10:4035–4044.
   PubMed Web of Science ®Google Scholar
• Jackson, P. K., and D. Baltimore. 1989. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-Abl. EMBO J. 8:449–456.
   PubMed Web of Science ®Google Scholar
• Kipreos, E. T., and J. Y. J. Wang. 1992. Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA. Science 256:382–385.
   PubMed Web of Science ®Google Scholar
• Konopka, J. B., S. M. Watanabe, and O. N. Witte. 1984. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 37:1035–1042.
   PubMed Web of Science ®Google Scholar
• Liu, J., M. Campbell, J. Q. Guo, D. Lu, Y. M. Xian, B. S. Andersson, and R. B. Arlinghaus. 1993. BCR-ABL tyrosine kinase is autophosphorylated or transphosphorylates pl60 BCR on tyrosine predominantly within the first BCR exon. Oncogene 8:101–109.
   PubMedGoogle Scholar
• Lugo, T. G., and O. N. Witte. 1989. The BCR/ABL oncogene transforms Rat-1 cells and cooperates with v-myc. Mol. Cell. Biol. 9:1263–1270.
   PubMed Web of Science ®Google Scholar
• Lupas, A., M. Van Dyke, and J. Stock. 1991. Predicting coiled coils from protein sequences. Science 252:1162–1164.
   PubMed Web of Science ®Google Scholar
• Maru, Y., and O. N. Witte. 1991. The BCR gene encodes a novel serine/threonine kinase activity within a single exon. Cell 67: 459–468.
   PubMed Web of Science ®Google Scholar
• McLaughlin, J., E. Chianese, and O. N. Witte. 1989. Alternative forms of the BCR/ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells. Mol. Cell. Biol. 9:1866–1874.
   PubMed Web of Science ®Google Scholar
• McWhirter, J. R., and J. Y. J. Wang. 1991. Activation of tyrosine kinase and microfilament-binding functions of c-Abl by Bcr sequences in Bcr-Abl fusion proteins. Mol. Cell. Biol. 11:1553–1565.
   PubMed Web of Science ®Google Scholar
• McWhirter, J. R., and J. Y. J. Wang. 1993. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J. 12:1533–1546.
   PubMed Web of Science ®Google Scholar
• McWhirter, J. R., and J. Y. J. Wang. Unpublished results.
   Google Scholar
• Mes-Masson, A. M., J. McLaughlin, G. Q. Daley, M. Paskind, and O. N. Witte. 1986. Overlapping cDNA clones define the complete coding region for the p210bcr-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome. Proc. Natl. Acad. Sci. USA 83:9768–9772.
   PubMed Web of Science ®Google Scholar
• Mitchell, P. J., and C. S. Cooper. 1992. The human tpr gene encodes a protein of 2094 amino acids that has extensive coiled-coil regions and an acidic C-terminal domain. Oncogene 7:2329–2333.
   PubMedGoogle Scholar
• Muller, A. J., A. M. Pendergast, M. H. Havlik, L. Puil, T. Pawson, and O. N. Witte. 1992. A limited set of SH2 domains binds BCR through a high-affinity phosphotyrosine-independent interaction. Mol. Cell. Biol. 12:5087–5093.
   PubMed Web of Science ®Google Scholar
• Muller, A. J., J. C. Young, A. M. Pendergast, M. Pondel, R. N. Landau, D. R. Littman, and O. N. Witte. 1991. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol. Cell. Biol. 11:1785–1792.
   PubMed Web of Science ®Google Scholar
• O’Shea, E. K., R. Rutkowski, and P. S. Kim. 1992. Mechanism of specificity in the Fos-Jun oncoprotein heterodimer. Cell 68:699–708.
   PubMed Web of Science ®Google Scholar
• Pendergast, A. M., R. Clark, E. S. Kawasaki, F. P. McCormick, and O. N. Witte. 1989. Baculovirus expression of functional p210 BCR-ABL oncogene product. Oncogene 4:759–766.
   PubMedGoogle Scholar
• Pendergast, A. M., M. L. Gishizky, M. H. Havlik, and O. N. Witte. 1993. SHI domain autophosphorylation of p210 BCR/ ABL is required for transformation but not growth factor independence. Mol. Cell. Biol. 13:1728–1736.
   PubMed Web of Science ®Google Scholar
• Pendergast, A. M., A. J. Muller, M. H. Havlik, Y. Maru, and O. N. Witte. 1991a. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner. Cell 66: 161–171.
   PubMed Web of Science ®Google Scholar
• Richardson, J. M., A. O. Morla, and J. Y. J. Wang. 1987. Reduction in protein tyrosine phosphorylation during differentiation of human leukemia cell line K562. Cancer Res. 47:4066–4070.
   PubMed Web of Science ®Google Scholar
• Ron, D., M. Zannini, M. Levis, R. B. Wickner, L. T. Hunt, G. Graziani, S. R. Tronick, S. A. Aaronson, and A. Eva. 1991. A region of proto-dbl essential for its transforming activity shows sequence similarity to a yeast cell cycle gene, CDC24, and the human breakpoint cluster region gene, bcr. New Biol. 3:372–379.
   PubMedGoogle Scholar
• Scharfmann, R., J. H. Axelrod, and I. M. Verma. 1991. Longterm in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. Natl. Acad. Sci. USA 88:4626–4630.
   PubMed Web of Science ®Google Scholar
• Shtivelman, E., B. Lifshitz, R. P. Gale, and E. Canaani. 1985. Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature (London) 315:550–554.
   PubMed Web of Science ®Google Scholar
• Shtivelman, E., B. Lifshitz, R. P. Gale, B. A. Roe, and E. Canaani. 1986. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell 47:277–284.
   PubMed Web of Science ®Google Scholar
• Ullrich, A., and Y. Schlessinger. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203–212.
   PubMed Web of Science ®Google Scholar
• Van Etten, R. A., P. Jackson, and D. Baltimore. 1989. The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 58:669–678.
   PubMed Web of Science ®Google Scholar
• Wang, J. Y. J. 1985. Isolation of antibodies for phosphotyrosine by immunization with a v-abl oncogene-encoded protein. Mol. Cell. Biol. 5:3640–3643.
   PubMedGoogle Scholar
• Wang, J. Y. J. 1993. Abl tyrosine kinase in signal transduction and cell-cycle regulation. Curr. Opin. Genet. Dev. 3:35–43.
   PubMedGoogle Scholar
• Weiner, D. B., J. Liu, J. A. Cohen, W. V. Williams, and M. Greene. 1989. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature (London) 339: 230–231.
   PubMed Web of Science ®Google Scholar